Vodafone Group Plc American Depositary Shares vs Zimmer Biomet Holdings Inc — how do they compare? Vodafone Group Plc American Depositary Shares trades at $15.56 (market cap $38.08B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Vodafone Group Plc American Depositary Shares is far larger — about 2.2× Zimmer Biomet Holdings Inc's market cap, and Vodafone Group Plc American Depositary Shares pays the higher dividend (3.26%). Which is the better fit depends on your goals — on Pluang, investors hold Vodafone Group Plc American Depositary Shares for 0 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| VOD | ZBH | |
|---|---|---|
Market Cap | $38.08B | $16.95B |
Volume | 3,820,235 | 2,505,240 |
Sector | Media | Health |
52-Week High | $17.68 | $103.98 |
52-Week Low | $11.17 | $79.58 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $83.23B | $24.02B |
Dividend Yield | 3.26% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% on the day, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and maintains a solid gross profit margin of 69.87%. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated. Analyst consensus is a 'Buy' with a $103.11 price target, indicating potential upside from current levels.
The outlook for ZBH is cautiously optimistic, supported by earnings momentum and a diversified medical technology portfolio. Key risks include rising debt levels, with debt-to-asset ratio increasing to 32.57% in 2025, and competitive pressures in the healthcare sector. Institutional ownership trends show continued interest, but investors should monitor margin sustainability and capital expenditure efficiency.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Vodafone provides mobile, fixed-line, broadband, and business communications services. It operates across Europe and Africa.
Read more on VOD →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →